Results 241 to 250 of about 29,718 (289)

Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial. [PDF]

Hum Vaccin Immunother
Perroud A, Madruga JVR, Fernandes L, Luz K, Lukic N, Bourée S, Sanchez-Ruiz M, Pegoraro F, Petit C, Zambrano B, Dayan G.   +10 more
europepmc   +1 more source

A Seroprevalence Survey of Dengue Virus Infection in Healthy Singapore University Undergraduates by Enzyme Immunoassay and Plaque Reduction Neutralization Test

, 2005
Vincent Chow, C.S. Lim, Meng Chee Phoon, Hwee Cheng Tan   +3 more
openalex   +1 more source

Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024. [PDF]

mBio
Jeworowski LM, Mühlemann B, Walper F, Schmidt ML, Jansen J, Krumbholz A, Jones TC, Corman VM, Drosten C.   +8 more
europepmc   +1 more source

Tandem split-GFP influenza A viruses for sensitive and accurate replication analyses. [PDF]

Microbiol Spectr
Nath H, Arndt A, Mann JT, Baker SF.
europepmc   +1 more source

Immunoproteasome inhibition triggers protein stress and apoptosis in cells of B cell lineage without impairing vaccination-induced antibody responses. [PDF]

Cell Death Discov
Mink D, Oliveri F, Otto J, Kutsi N, Gonzalez Siebold C, Muchamuel T, Li J, Basler M.   +7 more
europepmc   +1 more source

Evolution and Viral Properties of the SARS-CoV-2 BA.3.2 Subvariant

Jule Z, Römer C, Hossen T, Sviridchik V, Reedoy K, Ganga Y, Silangwe S, Norman A, Karim F, Kekana D, Mahlangu B, Mnguni A, Nzimande A, Stock N, Bernstein M, Gosnell BI, Moosa MS, Wolter N, Khan K, Neher RA, Sigal A.   +20 more
europepmc   +1 more source

Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies and overcomes immune imprinting patterns

Bonifaz MA, Bhavsar D, Siegrist C, Didierlaurent A, Meyer B.   +4 more
europepmc   +1 more source